CyPath Lung sales triple year-over-year at bioAffinity
bioAffinity Technologies reported Q2 2026 CyPath Lung sales growth of over 200% to a new record driven by increased physician adoption and repeat utilization. The acceleration in t…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
bioAffinity Technologies reported Q2 2026 CyPath Lung sales growth of over 200% to a new record driven by increased physician adoption and repeat utilization. The acceleration in t…
Glimpse Group, Inc. entered into a Master Purchase Agreement to sell outstanding shares of its subsidiary to Glimpse Learning, Inc. This agreement outlines the transfer of technolo…
BIO-key International announced its shares will resume trading on Nasdaq starting July 8, following a panel's decision that the company has regained compliance with listing require…
Axos Financial agreed to acquire financial technology platform Arc Technologies. This deal aims to expand the company's AI capabilities and small business services.
Capstone Energy+ expects to begin trading on Nasdaq under the symbol CEPL on July 8, 2026, following a period of operational and financial transformation. This uplisting marks a si…
Lazard, Inc. announced the appointment of Kathy Elsesser to its board of directors, succeeding Andrew M. Alper who retired after 13 years. Elsesser brings Goldman Sachs investment …
Institutional holdings report (13F-HR) filed by Stark Wealth Management LLC.
Zapata CEO Sumit Kapur will present at the Global Technology Virtual Investor Conference on July 9th, discussing recent breakthroughs in quantum computing and AI. This interactive …
Breakthrough T1D awarded a grant to support the PRISE-hATG study evaluating SAB-142 for new-onset type 1 diabetes patients.
Theriva Biologics obtained regulatory authorization from the Spanish Agency for the VIRAGE2 clinical trial testing increased VCN-01 dosing in metastatic pancreatic cancer. This stu…
Institutional holdings report (13F-HR) filed by FIRST FINANCIAL CORP /IN/.
Aptera Motors received an EPA Certificate of Conformity for its 2026 Launch Edition, confirming emissions compliance for U.S. sale. This regulatory milestone brings the company clo…
Turn Therapeutics revealed the final adaptive Stage 2 design for its atopic dermatitis drug GX-03 after observing clinically meaningful efficacy across various disease severities. …
Envirotech closed its merger with Azio AI ahead of schedule to capitalize on the projected $487 billion AI infrastructure market. The combined company is actively deploying modular…
Digi Power X began generating revenue through its NeoCloudz platform and reported $155 million in cash as of July 2026. The company's secured equipment and strong balance sheet sup…
Vaxart reported top-line safety data for its Phase 2b oral COVID-19 vaccine, finding no vaccine-related serious adverse events or sustained Grade 3 adverse events. This positive re…
Vivani Medical agreed to merge with ClearOne. This merger could signal a strategic shift or consolidation within the technology and compensation sectors.
MeiraGTx Holdings plc has entered into a Royalty Note Purchase Agreement with Maverick SA LLC to issue notes to designated purchasers. This transaction provides a financing mechani…
Tvardi announced positive Phase 1 results for its STAT3 prodrug TTI-109, demonstrating target engagement and significantly improved tolerability compared to the parent compound. Th…
D-Wave is one of only two companies named to the Leaders category in the IDC assessment. This highlights the company's strong commercial traction and enterprise cloud platform adop…